Facebook
Twitter
LinkedIn
Forward
Updates in Internal Medicine 2024: Practice Changing Advances
Target Audience
Physician, Advanced Practice Provider, Nurse, Nurse Practitioner, Pharmacist, Physician Assistant, and Other Healthcare Professional.
Learning Objectives
Upon completion of this course, participants should be able to:
- Define care management pathways for common diseases encountered in primary care including dyspnea, prostate cancer, depression, chronic kidney disease, dementia, hypersomnia, obesity, and dermatology challenges.
- Synthesize current scientific evidence for managing cerebrovascular disease, motility disorders of the GI tract, atrial arrhythmias, acute pain in the hospitalized patient with substance use disorders, smoking cessation, and antibody screening in rheumatic disorders.
- Analyze the impact and outcomes of newer anticoagulation agents, medical marijuana, preventive cardiology, medication use in the elderly population, home antibiotic management, travel medicine, and sharing your DNA for analysis.
Additional Information
Faculty Disclosure Statement:
All individuals in a position to control the content of this education activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships for the individuals listed below have been mitigated.
Jaideep Behari, MD, PhD-
Grant/research support with Gilead Sciences, Pfizer, AstraZeneca, Endra Life Sciences.
Institutional research contracts: Intercept, Pfizer, Inventiva, Akero, Rhythm, Galectin, Madrigal.
Mehak Dhande, MD-
Grant/research support: Donation of tech resources by Lucia Guidelines.
Consultant: Cortex.Inc (consultant), Dune Health (Advisor), Nurse Brain (Advisor)
Holly Thomas, MD-
Member of the Board of Trustees of The Menopause Society
Nicolette Machin, MD-
Grant/research support: Takeda
Consultant: Sanofi
Gayle Gordillo, MD-
Consultant: Vertex Pharmaceuticals
Stockholder (privately held): MedCompliance LLC
Brandon Smith, MD, PharmD-
Consultant: Shionogi, Inc
CE Speakers’ Bureau: Shionogi, Inc; Melinta Therapeutics
Marcio Bittencourt, MD-
Consultant: Elucid
CE Speakers’ Bureau: Cleerly
Sebastian E. Sattui, MD-
Grant/research support: Clinical trials: GlaxoSmithKline, Amgen. Career Development Award: Bristol Myers Squibb Foundation
Consultant: Amgen, Sanofi (all funds toward research support)
CE Speakers’ Bureau: Fresenius Kabi (all funds toward research support)
Rheumatology Research Foundation, National Institute of Aging
Jennifer Berliner, MD-
Consultant: Marvin Behavioral Health Inc, Viz Ai, AMC Health
Jonathan Arnold, MD-
Grant/research support: Pfizer, Amgen, Exelixis, Bristol Myers Squibb, Merck
Jane Liebschutz, MD-
Consultant: Miomotivate, Inc.
Linda Fried, MD-
Grant/research support: Astra Zeneca- paid to VA
Consultant: DSMB member: Novonordisk, Regeneron
Stockholder (publicly traded): Amgen
Manisha Jhamb, MD-
Grant/research support: DCI, Bayer, Pfizer, CKD Leaders network
Consultant: Boehringer-Ingelheim, Eli-Lilly
Anum Saeed, MD-
Grant/research support: American Heart Association (Recipient of Career Development Award)
Shivdev Rao, MD-
Grant/research support: Abridge AI, Inc.
Helbert Rondon Berrios-
ABIM Nephrology LKA approval committee member, Remunerated for work as an expert witness in cases related to the treatment of hyponatremia by attorneys for both plaintiff and defense
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Accreditation and Credit Designation
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity enables the participant to earn MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn ABIM MOC points equivalent to the amount of CME credits claimed for the activity.
Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 14.5 contact hours.
Pharmacotherapeutic/pharmacology content contained within each presentation has been calculated and designated in the course agenda. The total hours will be noted on your certificate. Click here for a specific list of the hours awarded for each presentation.
Pharmacy (CPE)
This knowledge-based activity provides 11.0 contact hours of continuing pharmacy education credit. Click here for a list of the presentations designated for pharmacy credit.
Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 14.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Available Credit
- 14.50 AAPA Category I CME
- 11.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
- 14.50 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 14.50 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 3.75 Pharmacotherapeutic
- 14.50 Attendance
Price
Registration Categories | Early Bird Registration by September 30th at 5:00p | Regular Registration until October 24th at 12:00p |
MD and DOs | $265 | $285 |
PharmDs, APP, Nurses, PAs, and other HCPs | $165 | $185 |
1st Year Practicing MD, DOs, PharmDs, APPs, Nurses, and PAs | Fee Waived | Fee Waived |
Residents, Fellows, and PGY 1s and PGY 2s | Fee Waived | Fee Waived |
Cancellation Policy:
Registration cancellations must be sent via email to domuim@upmc.edu no later than Wednesday, October 9, 2024, by 11:59 pm. No telephone cancellations will be accepted. Refunds will be issued via the original form on payment. No refunds will be issued, for any reason, after Wednesday, October 6, 2024, at 11:59 pm.
Participation by all individuals is highly encouraged. Advance notification of any special needs will help us provide better service. Please notify us of your needs at least two weeks in advance of the program by email domuim@upmc.edu or calling 412-376-7123.